Trial Profile
Retrospective matched case-control study of Bortezomib along with Melphalan and Dexamethasone in patients with AL amyloidosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone; Melphalan
- Indications Amyloid light-chain amyloidosis
- Focus Therapeutic Use
- 03 Dec 2015 New trial record